tiprankstipranks
Genor Biopharma Holdings Limited (HK:6998)
:6998
Hong Kong Market
6998
Genor Biopharma Holdings Limited
RESEARCH TOOLSreports
Want to see HK:6998 full AI Analyst Report?

Genor Biopharma Holdings Limited (6998) Financial Statements

3 Followers

Genor Biopharma Holdings Limited Financial Overview

Genor Biopharma Holdings Limited's market cap is currently HK$5.92B. The company's EPS TTM is HK$0.24; its P/E ratio is 2.00; Genor Biopharma Holdings Limited is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 2.42B¥ 206.23M¥ 0.00¥ 15.93M¥ 0.00
Gross Profit¥ 1.34B¥ 204.89M¥ 0.00¥ 14.95M¥ 0.00
Operating Income¥ 619.27M¥ -72.55M¥ -711.20M¥ -786.21M¥ -859.11M
EBITDA¥ 929.10M¥ -5.15M¥ -551.01M¥ -675.89M¥ -840.19M
Net Income¥ 388.93M¥ -51.28M¥ -674.36M¥ -730.40M¥ -865.37M
Balance Sheet
Cash & Short-Term Investments¥ 1.06B¥ 1.06B¥ 1.17B¥ 1.59B¥ 2.20B
Total Assets¥ 6.61B¥ 1.29B¥ 1.45B¥ 2.12B¥ 2.86B
Total Debt¥ 1.49B¥ 911.00K¥ 7.16M¥ 28.59M¥ 57.41M
Net Debt¥ 431.36M¥ -1.06B¥ -1.16B¥ -1.56B¥ -2.14B
Total Liabilities¥ 2.75B¥ 138.05M¥ 256.18M¥ 309.87M¥ 369.73M
Stockholders' Equity¥ 3.86B¥ 1.15B¥ 1.19B¥ 1.80B¥ 2.49B
Cash Flow
Free Cash Flow¥ 404.05M¥ -123.55M¥ -426.15M¥ -590.56M¥ -695.13M
Operating Cash Flow¥ 451.73M¥ -121.98M¥ -425.12M¥ -577.61M¥ -623.74M
Investing Cash Flow¥ 1.24B¥ 8.01M¥ 5.99M¥ -12.94M¥ -54.26M
Financing Cash Flow¥ -744.78M¥ -1.56M¥ -6.82M¥ -57.39M¥ 17.57M
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History

Income Statement >

Genor Biopharma Holdings Limited Debt to Assets

Balance Sheet >

Genor Biopharma Holdings Limited Cash Flow

Cash Flow >

Genor Biopharma Holdings Limited Forecast EPS vs Actual EPS

Earnings >